Naomi Kurata
Showa University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Naomi Kurata.
Integrated Pharmacy Research and Practice | 2016
Nobuo Yamamoto; Mitsuyo Nitta; Miwako Kamei; Kazuo Hara; Fumiyuki Watanabe; Keiko Akagawa; Naomi Kurata
Purpose This study was conducted to evaluate whether a community pharmacist’s assistance during the treatment of a patient with a chronic illness would help to discover and improve issues regarding the treatment. Method We employed a prospective intervention study with a control group. The patients ranging in age from 60 to 74, were using one of the six selected community pharmacies in the Tokyo metropolitan area. They had been prescribed six or fewer kinds of medications, one of which was amlodipine. The medication dosages covered 1 month or longer. Patients who agreed to participate in the study were randomly assigned to the groups at each pharmacy. For the patients in the intervention group, the pharmacists provided telephone counseling between physician visits, in addition to the time they visited the pharmacies to collect their medications. For the patients in the control group, the pharmacists provided counseling only at their pharmacies. Results and discussion The average days of medication administration were 49.2 days for the 58 patients in the intervention group, and 49.8 days for the 53 patients in the control group, with the average number of medications being 3.4 items per person for both groups. Through the telephone counseling, we were able to collect more information, eg, changes in physical condition and occurrences of side effects, from the intervention group than from the control group. The rate of incident detection in the information from the intervention group was five times that of the control group, making subsequent incident resolutions faster. Conclusion This study suggested that phone counseling between physician visits could enable the identification of more issues regarding patients’ conditions.
The Journal of Medical Investigation | 2018
Takahiro Niimura; Yoshito Zamami; Toru Imai; Tsuyoshi Ito; Hidenori Sagara; Hichiya Hiroyuki; Satoru Esumi; Kenshi Takechi; Masaki Imanishi; Toshihiro Koyama; Manabu Amano; Naomi Kurata; Yoshihisa Kitamura; Hironori Nakura; Toshiaki Sendo; Keisuke Ishizawa
n emergency and critical care medical centers, tube administration is employed for patients who have difficulty swallowing oral drugs owing to decreased consciousness or mechanical ventilation. However, tube clogging due to drug injection is a concern. We compared the crushing method with the simple suspension method for the passage of amlodipine, an antihypertensive drug, in combination with rikkunshito, which has been used to treat upper gastrointestinal disorders such as functional dyspepsia and gastroesophageal reflux in emergency and critical care medical centers, to ascertain the effect of Kampo products on the passage of other drugs during tube administration. When the crushing method was employed, poorly water-soluble solid products were formed, while a uniformly dispersed suspension was obtained using the simple suspension method. In addition, the passage rate of amlodipine through the tube was 64% and 93% in the crushing and simple suspension methods, respectively, thereby indicating that the simple suspension method provided more favorable than the crushing method. The results of this study suggested that the passage rate of amlodipine for patients who received Kampo products concurrently was higher when the simple suspension method was used, and an appropriate drug amount might well be able to administered to patients using this method. J. Med. Invest. 65:32-36, February, 2018.
BMC Research Notes | 2017
Keita Shibata; Koichi Ichikawa; Naomi Kurata
BackgroundAnti-doping activities are carried out on a global scale. Based on these activities, the specialty of “sports pharmacist,” which entails a deeper comprehension of doping, use of supplements, and appropriate drug use for athletes, was established in 2009 in Japan. It is difficult to say whether the education on doping is adequate for pharmacy students who will be eligible to become sports pharmacists. It is also unclear how well these students understand doping. Therefore, the aim of this study was to investigate pharmacy students’ current knowledge of appropriate drug use, doping and use of supplements, and to explore the need for further education on these topics.MethodsA questionnaire survey was conducted from July 3rd to August 2nd in 2014 at Showa University in Japan. A total of 406 respondents (2nd- to 6th-year students) were assessed as eligible. Group comparison was used to compare those who had attended a lecture about doping and those who had not.ResultsMost of the students only knew the word doping and had not attended a lecture on the subject, but 72% of them expressed a desire to attend one. Over half did not know that the most common doping violation in Japan is unintentional doping, and were unfamiliar with certain past cases of doping. In addition, 41% did not know that over-the-counter medicines and dietary supplements might contain prohibited substances, and 87% were unaware that names of prohibited substances might not appear on the ingredient labels of dietary supplements. In contrast, attending a lecture on doping was effective in facilitating the acquisition of all these types of knowledge.ConclusionsIt is important to provide more opportunities for appropriate education of pharmacy students on the topic of doping, given that interest exists and attending a lecture on the topic appears to be useful. More education about doping for pharmacy students would be as effective for anti-doping activities as is education of athletes.
Japanese Journal of Pharmaceutical Health Care and Sciences | 2010
Hiromichi Asakura; Masumi Misina; Naomi Kurata; Takashi Itoh; Michiko Amemiya
Epadel S®,a seamless capsule form of ethyl icosapentate (EPA-E),was made into a suspension in 20 ml of hot water (55°C) and stirred with a polystyrene (PS) disposable spoon.When left in the suspension,the surface of the spoon started to dissolve after 45 minutes,and was completely dissolved after 12 hours.We also investigated the dissolution of PS utensils in suspensions made from teprenone (Selbex®) capsules or powder,or gefarnate (Gefanil®) capsules.Up till now,there have been no reports of toxicity due to PS or the non-reactants and/or by-products produced in the PS production process.However,as the dissolution of spoons,cups or other common utensils made of PS in drug suspensions could cause concern among patients,caregivers,and medical staff,it is important to instruct them to avoid the use of such utensils when preparing drug suspensions.
Japanese Journal of Pharmaceutical Health Care and Sciences | 2006
Katsuko Yano; Takashi Takezawa; Toshihide Mochizuki; Nobutomo Ikarashi; Kiyomi Ito; Takao Orii; Naomi Kurata; Kiyoshi Sugiyama
Japanese Journal of Pharmaceutical Health Care and Sciences | 2001
Naomi Kurata; Chie Komatsu; Akira Heito; Yoshiaki Mori
Japanese Journal of Pharmaceutical Health Care and Sciences | 2013
Nelly Suryani; Erika Sugiyama; Naomi Kurata; Hitoshi Sato
Japanese Journal of Pharmaceutical Health Care and Sciences | 2008
Katsuko Yano; Nobutomo Ikarashi; Kiyomi Ito; Takao Orii; Naomi Kurata; Junichi Iida; Kiyoshi Sugiyama
Biological & Pharmaceutical Bulletin | 2016
Keita Shibata; Arisa Matsumoto; Ayumi Nakagawa; Keiko Akagawa; Akihiro Nakamura; Toshinori Yamamoto; Naomi Kurata
Japanese Journal of Pharmaceutical Health Care and Sciences | 2009
Isao Saito; Mari Kogo; Jun-ichi Mashimo; Naomi Kurata; Yasuna Kobayashi; Jun-Ichiro Murayama; Ken-ichi Saguchi; Nam-Ho Choi-Miura; Hiroaki Ohi; Miwako Kamei; Takashi Tobe; Toshinori Yamamoto